NVS said it was suing rival LLY in U.S. federal court, accusing the U.S. drugmaker of false advertising in claiming its weight-loss Medicine
NVS said it was suing rival LLY in U.S. federal court, accusing the U.S. drugmaker of false advertising in claiming its weight-loss Medicines outperform Novo's drugs.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.